glp-1 pharma companies Did you know? India is now the world's 2nd largest GLP‑1 market. With 2026 patent expiries ahead, a massive opportunity could open up in diabetes & obesity care #MarketTalks #EdelweissMutualFund glp 1 pharmaceutical companies GLP-1

For optimal management, those with prediabetes and T2D should likely maintain a moderate protein diet and ensure that their protein consumption is evenly spaced throughout the day, avoiding high protein meals

Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease

Compounded semaglutide has grown in popularity during shortages, but compounded drugs are not approved by the Food and Drug Administration (FDA)

My goal is to help patients find a treatment plan that is realistic, medically appropriate, and sustainable long term. Dr

Jarosz M, Olbert M, Wyszogrodzka G, Myniec K, Librowski T

Weight Loss and Mechanical Unloading : The most significant factor affecting bone density in patients taking GLP-1 medications is likely the substantial weight loss these agents produce